Ophthalmology · East Setauket, NY
NPI
1154326122
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4 Technology Dr, Suite 150
East Setauket, NY, 11733
Phone (631) 941-1400
Groups this clinician bills Medicare through
Medicare paid, 2024
$408K
4,059 services
Medicare patients, 2024
1,703
Average age 78
Drug cost, 2024
$1.1M
2,162 prescriptions
Company payments, 2025
$152
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John R Wittpenn was code 92014 (ophthalmological e&m), 1,293 times for 1,211 patients. In total John R Wittpenn billed 4,059 services in 44 codes, and Medicare paid $408K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 1,293 | 1,211 | $102.26 | $132K |
| 99213 Office E&M - Established | Office | 851 | 534 | $78.27 | $67K |
| 83861 Clinical Chemistry | Office | 572 | 250 | $21.95 | $13K |
| 99214 Office E&M - Established | Office | 229 | 206 | $101.81 | $23K |
| 92134 Computerized Ophthalmic Imaging | Office | 225 | 216 | $34.58 | $7,780 |
| 92136 Ultrasound - Nonspecific | Office | 150 | 126 | $35.55 | $5,333 |
| 66984 Cataract Surgery | Facility | 146 | 113 | $479.00 | $70K |
| 92025 Test - Miscellaneous | Office | 65 | 56 | $30.08 | $1,955 |
| 66821 Cataract Surgery | Office | 62 | 56 | $299.23 | $19K |
| 92133 Computerized Ophthalmic Imaging | Office | 60 | 57 | $31.45 | $1,887 |
| 92004 Ophthalmological E&M | Office | 59 | 59 | $107.68 | $6,353 |
| 99204 Office E&M - New | Office | 43 | 43 | $126.43 | $5,437 |
| 92250 Angiography | Office | 41 | 41 | $29.82 | $1,223 |
| 67820 Eye | Office | 39 | 32 | $16.53 | $645 |
| 92286 Standard X-ray | Office | 32 | 30 | $34.66 | $1,109 |
By year: 2022 $588K for 5,536 services; 2023 $513K for 5,135 services; 2024 $408K for 4,059 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 572 | 250 | $21.95 | $13K |
| 83516 Immunoassay | 27 | 16 | $11.30 | $305 |
Medicare prescription drug claims, 2024
In 2024, the drug John R Wittpenn prescribed most often to Medicare patients was Prednisolone Acetate, with 542 prescriptions and refills. In total John R Wittpenn wrote 2,162 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 542 | 679 | 239 | $16K |
| Loteprednol Etabonate Generic | 308 | 418 | 101 | $44K |
| Ofloxacin Generic | 253 | 253 | 181 | $2,358 |
| Erythromycin Erythromycin Base | 109 | 109 | 50 | $1,055 |
| Valacyclovir Valacyclovir Hcl | 102 | 206 | 34 | $3,311 |
| Restasis Cyclosporine | 94 | 244 | 53 | $146K |
| Brimonidine Tartrate Generic | 63 | 95 | 19 | $3,529 |
| Prolensa Bromfenac Sodium | 60 | 62 | 39 | $22K |
| Latanoprost Generic | 56 | 119 | 22 | $650 |
| Cyclosporine Generic | 42 | 108 | 21 | $32K |
| Xiidra Lifitegrast | 42 | 86 | 15 | $54K |
| Eysuvis Loteprednol Etabonate | 38 | 47 | 23 | $18K |
| Difluprednate Generic | 37 | 43 | 14 | $5,024 |
| Ilevro Nepafenac | 33 | 37 | 21 | $12K |
| Doxycycline Hyclate Generic | 32 | 61 | 15 | $591 |
Brand drugs: 1,356 claims; generic drugs: 806 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John R Wittpenn $152 ($152 in general payments such as food, travel and fees) from 2 companies. The largest payer was Glaukos Corporation with $128.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.